Every one of those 1 sits in a single category, medical-devices. Assure system is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Vaseem Mahboob
Every one of those 1 sits in a single category, medical-devices. Assure system is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. Their average consequence score of 6 runs above the beat's 5.8 for that window. Vaseem Mahboob appears in 1 tracked Healthcare story from March 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Vaseem Mahboob. Shared-story counts are live from our verified record — not editorial picks.
Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.